Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
INO compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
INO
Inovio Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
INO
Inovio Pharmaceuticals, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only INO
7
—
ApolloBio
unlisted
customer
CHRS
Coherus BioSciences
supplier
—
Vgxi
unlisted
supplier
—
Defense Advanced Research Projects Agency (DARPA)
unlisted
customer
3 more · INO chain
›
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›
INO
Inovio Pharmaceuticals, Inc.
Change
1.15
▼
−20.59%
Mkt cap
$149.9M
Revenue
$65,343
Q1 FY25
Revenue
—
LLY
ELI Lilly & Co
Change
1,363.60
▼
−0.08%
Regular session
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 6 '26
INO
Inovio Pharmaceuticals, Inc.
vs
LLY
ELI Lilly & Co
1.15
▼
−20.59%
Price
1,363.60
▼
−0.08%
$149.9M
Mkt cap
$1.2T
Q1 FY25
$65,343
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
INO
1.15
▼
−20.59%
vs
LLY
1,363.60
▼
−0.08%
Regular session
Nov 6 '26